BD reports FY26 revenues of $19.5bn after medtech prioritisation
BD spun out its diagnostics business in a $17.5bn deal with Waters Corporation in June 2025 in order to prioritise…
BD spun out its diagnostics business in a $17.5bn deal with Waters Corporation in June 2025 in order to prioritise…
Edwards 11.2% YoY growth in Q3 was driven by sales growth in its TAVR and TMTT segments at 8% and…
BD spun out its diagnostics business in a $17.5bn deal with Waters Corporation in June 2025 in order to prioritise…
Edwards 11.2% YoY growth in Q3 was driven by sales growth in its TAVR and TMTT segments at 8% and…
Arkstone Next is designed to assist healthcare personnel in rural clinics, skilled nursing facilities, and urgent care centres.
The technology remains under active development and has not received regulatory clearance or approval.
The orthopaedics giant now expects 2026 earnings to land in the $8.50-$8.60 per share range.
The DoJ settlement relates to Philips subsidiary Respironics global recall of 15 million faulty sleep apnoea devices in 2021.
Experts note that Democrats are likely to place Trump’s MFN deals under the microscope, while looking to reverse sweeping Medicaid…
AutoAS offers a visual estimation of moderate-to-severe aortic stenosis by assessing standard 2D echocardiographic views.
DermaForm provides a structure to support tissue healing and protects wounds when primary closure cannot take place.
Oath Surgical currently operates three outpatient surgical centres in Oregon and Arizona.